DG
David E. Goel
10% Owner

David E. Goel insider trades: Aura Biosciences (AURA) stock buys and sales

10% Owner, Aura Biosciences Last trade May 7, 2026 25 Form 4 filings
$49.0M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2014
7
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

and 1 more company

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 7, 2026AURA↓ Sell$39.0M
Dec 15, 2025ZNTL↓ Sell$10.0M
Nov 9, 2023AURA↑ Buy$14.0M
Jun 20, 2023ZNTL↑ Buy$107.9M
Dec 5, 2022AURA↑ Buy$15.0M
Nov 2, 2021AURA↑ Buy$25.0M
Mar 10, 2021ADPT↓ Sell$32.2M
Jul 20, 2020ADPT↓ Sell$80.0M
May 15, 2014BPOP↓ Sell$13.2M
May 15, 2014BPOP↓ Sell$226K
Jan 30, 2014BPOP↓ Sell$27.1M
Jan 30, 2014BPOP↓ Sell$528K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AURA insiders

Open-market trades in the last 12 months

About David E. Goel's insider trades

David E. Goel is a 10% owner of Aura Biosciences (AURA). Since Jan 30, 2014, David has reported 4 open-market purchases worth $161.9M and 8 sales worth $202.4M on SEC Form 4. In the last 12 months: 2 sales ($49.0M).

Their filings also include grants and awards (8 filings), conversions (5 filings), other transactions (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AURA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.